Management of NSAIDs in Patients with Dyspepsia

The American College of Cardiology recommends that NSAIDs should not be routinely given to patients with existing dyspepsia, as they significantly worsen symptoms and increase the risk of serious gastrointestinal complications, including ulcers, bleeding, and death 1, 2, 3, 4.
NSAIDs cause dyspepsia in 10-20% of users and can worsen pre-existing dyspeptic symptoms, according to the American Academy of Family Physicians 5.

Clinical Approach to NSAID Use

The American Geriatrics Society recommends that the safest approach is to avoid NSAIDs entirely in patients with dyspepsia, and consider alternative analgesics such as acetaminophen for pain management 7, 8.
Endoscopy is recommended in patients presenting with dyspeptic symptoms who require NSAID therapy, because of the risk of potentially life-threatening ulcer complications, as suggested by the Gut journal 3, 4.

The Gut journal suggests that previous history of peptic ulcer disease, age >60 years, concomitant glucocorticosteroid use, concomitant anticoagulant therapy, and concomitant low-dose aspirin are major risk factors that mandate gastroprotective co-therapy 3, 4, 5, 1, 2, 6.
Proton pump inhibitors (PPIs) are superior for both healing and prophylaxis compared with placebo, misoprostol, and ranitidine, according to the Gut journal 3, 4.

The Journal of the American Geriatrics Society recommends that for patients requiring NSAIDs with risk factors, PPI co-therapy with traditional NSAID is the preferred approach, while COX-2 selective inhibitor (celecoxib) alone provides some GI protection but not complete 7, 8, 9.
Misoprostol co-therapy is effective but poorly tolerated due to diarrhea, and high-dose H2-receptor antagonists are less effective than PPIs, as reported by the Gut journal and the Journal of the American Geriatrics Society 3, 4, 7, 8.

The American College of Cardiology advises that never assuming dyspepsia symptoms correlate with ulcer presence, as patients can have severe ulceration without symptoms and vice versa 1, 2, 6.
The Gut journal warns against prescribing NSAIDs without gastroprotection in patients over 60 years, as age is a major independent risk factor 3, 4.
The Journal of the American Geriatrics Society notes that COX-2 inhibitors are not completely safe, as they still cause ulcers and complications, particularly when combined with aspirin 1, 2, 6, 7, 8.